Stay updated on Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.5.4) replacing the previous v3.5.3, signaling a version update of the page. It does not reflect changes to the study content or results.
    Difference
    0.1%
    Check dated 2026-05-16T09:19:41.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    A revision/version string on the ClinicalTrials.gov page was updated from v3.5.2 to v3.5.3, reflecting an interface or backend site release rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T22:18:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:10:56.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:52:23.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. It appears to be a backend/UI update with no visible changes to study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-12T20:20:05.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    The change consists of Revision: v3.4.2 replacing v3.4.1, which appears to be a metadata/version update without altering study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:14.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.